Partnering with patients with kidney disease and their caregivers to achieve health, longevity, and quality of life equivalent to the general population.
IROC BY THE NUMBERS
“The greatest obstacle to improving long-term outcomes for children with kidney disease is not the lack of available therapies, but rather the lack of effective healthcare delivery systems that implement existing therapies reliably in clinical practice.”
— David K. Hooper MD, MS, Medical Director of Kidney Transplantation at Cincinnati Children's Hospital and Principal Investigator of IROC